Diabetes, Autoimmune: Clinical Trials

2 trials for Diabetes, Autoimmune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Diabetes, Autoimmune: new trials by email Literature Review of Diabetes, Autoimmune trials Research Report on Diabetes, Autoimmune

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low-dose IL-2 in Established T1D - The "PROREG" Study
ILT-101 (Aldesleukin; IL-2), Treatment-Placebo Arm, Placebo Arm - Diabetes Mellitus, Type 1, Diabetes
Phase 1 / Phase 2WithdrawnJay S. Skyler2023-06-012024-05-22
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
Cholecalciferol, Omega 3 fatty acid - Diabetes Mellitus, Type 1, Hypoglycemia
Phase 1 / Phase 2CompletedRodolfo Alejandro272018-07-232025-09-17

Narrower conditions

Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Hypoglycemia (1)

Broader conditions

Autoimmune Diseases (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Immune System Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

Cholecalciferol (1)  ·  Docosahexaenoic Acids (1)  ·  Fatty Acids, Omega-3 (1)  ·  Interleukin-2 (1)  ·  Vitamin D (1)  ·  aldesleukin (1)

Sponsors

Jay S. Skyler (1)  ·  Rodolfo Alejandro (1)

Countries

United States (2)

Top investigators

Alberto Pugliese, M.D. (1)  ·  Camillo Ricordi, M.D. (1)  ·  David A Baidal, M.D. (1)  ·  Jay S Skyler, M.D. (1)